Estonia vs High income: Cause of death, by non-communicable diseases, ages 5-14, male
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Estonia
- High income
How they compare
Estonia currently reports 75.0% against 49.8% in High income, a difference of 25.2%.
That makes Estonia's figure about 1.5 times High income's.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was High income ahead.
Estonia ranks 4th and High income ranks 6th of 185 countries.
Across the 3 decades both report, Estonia averaged higher in 1 and High income in 2.
Head to head by decade
| Decade | Estonia | High income | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.1% | 38.5% | 3.4% | High income |
| 2010s | 42.0% | 49.6% | 7.6% | High income |
| 2020s | 55.6% | 50.0% | 5.5% | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Estonia or High income?
- Estonia, at 75.0% against 49.8% in High income as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Estonia and High income?
- 25.2%, with Estonia ahead.
- How many years of comparable data are there for Estonia and High income?
- 6 years are reported by both, from 2000 to 2021.
- How do Estonia and High income rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Estonia ranks 4th and High income ranks 6th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.